104 related articles for article (PubMed ID: 24302411)
1. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.
Pileggi C; Flotta D; Bianco A; Nobile CG; Pavia M
Int J Cancer; 2014 Jul; 135(1):166-77. PubMed ID: 24302411
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Smith JS
Gynecol Oncol; 2012 Apr; 125(1):175-80. PubMed ID: 22233689
[TBL] [Abstract][Full Text] [Related]
3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS
Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
6. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.
Poljak M; Oštrbenk A
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
[TBL] [Abstract][Full Text] [Related]
8. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
9. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India.
Sankaranarayanan R; Nene BM; Dinshaw KA; Mahe C; Jayant K; Shastri SS; Malvi SG; Chinoy R; Kelkar R; Budukh AM; Keskar V; Rajeshwarker R; Muwonge R; Kane S; Parkin DM; Chauhan MK; Desai S; Fontaniere B; Frappart L; Kothari A; Lucas E; Panse N;
Int J Cancer; 2005 Sep; 116(4):617-23. PubMed ID: 15818610
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance.
Klug SJ; Neis KJ; Harlfinger W; Malter A; König J; Spieth S; Brinkmann-Smetanay F; Kommoss F; Weyer V; Ikenberg H
Int J Cancer; 2013 Jun; 132(12):2849-57. PubMed ID: 23175270
[TBL] [Abstract][Full Text] [Related]
11. Impact of replacing cytology with human papillomavirus testing for cervical cancer screening on the prevalence of
Hui BB; Reulein CP; Guy RJ; Donovan B; Hocking JS; Law MG; Regan DG
Sex Transm Infect; 2018 May; 94(3):216-221. PubMed ID: 29326178
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy detection for diagnostic and prognostic use in premalignant and malignant lesions of the uterine cervix: A systematic review.
Costa AF; Ribeiro MGM; Onofre ASC; de Miranda Onofre FB
Diagn Cytopathol; 2021 Feb; 49(2):335-346. PubMed ID: 33332763
[TBL] [Abstract][Full Text] [Related]
13. Compare two different usages of FRD for detecting high-grade cervical lesions and invasive cancer.
Dai Y; Wang L; Li D
Arch Gynecol Obstet; 2019 May; 299(5):1399-1404. PubMed ID: 30838444
[TBL] [Abstract][Full Text] [Related]
14. Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.
Popadiuk C; Gauvreau CL; Bhavsar M; Nadeau C; Asakawa K; Flanagan WM; Wolfson MC; Coldman AJ; Memon S; Fitzgerald N; Lacombe J; Miller AB
Curr Oncol; 2016 Feb; 23(Suppl 1):S56-63. PubMed ID: 26985148
[TBL] [Abstract][Full Text] [Related]
15. Implementation of primary HPV testing in Japan.
Kurokawa T; Yoshida Y; Iwanari O; Oishi T; Kasai T; Hamada M; Fujita H; Fujiwara H; Yokoyama M; Sakuragi N; Kigawa J; Suzuki M
Mol Clin Oncol; 2020 Oct; 13(4):22. PubMed ID: 32765870
[TBL] [Abstract][Full Text] [Related]
16. New technologies in cervical cancer precursor detection.
Soler ME; Blumenthal PD
Curr Opin Oncol; 2000 Sep; 12(5):460-5. PubMed ID: 10975554
[TBL] [Abstract][Full Text] [Related]
17. [Uterine cervical cancer screening in Japan: today and future].
Matsuura Y; Kawagoe T; Toki N; Hachisuga T; Kashimura M
J UOEH; 2009 Jun; 31(2):181-93. PubMed ID: 19530563
[TBL] [Abstract][Full Text] [Related]
18. Cervical Cancer Screening of Adolescents Should Not Be Encouraged.
Henrique LQ; Campaner AB; dʼAvila FS
J Low Genit Tract Dis; 2017 Jan; 21(1):21-25. PubMed ID: 28027120
[TBL] [Abstract][Full Text] [Related]
19. Physicians say HPV testing alone can screen for cervical cancer.
Printz C
Cancer; 2015 Jul; 121(13):2105. PubMed ID: 26878557
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
